Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
75 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2024
VACCINE MONITORING COLLABORATION FOR EUROPE from Elsene, company number BE0741674866, closed financial year 2024 with a result of € 111,391 after tax. For that financial year VACCINE MONITORING COLLABORATION FOR EUROPE recorded a gross margin of € 110,769 and equity of € 1.5 million. Compared with financial year 2023, the result moved from € 262,626 to € 111,391. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2025.
€ 1.5 million
▲ 8% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 111,391
▼ 58% vs 2023
Profit after tax over the fiscal year.
€ 199,565
▼ 24% vs 2023
Cash and bank balances on the last day of the fiscal year.
Debts at end 2024
None
No bank loans on the last day of the fiscal year.
€ 131,457
▼ 26% vs 2023
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|
| Gross margin | € 257,853 | € 110,769 | ▼ 57% |
| Profit after taxes | € 262,626 | € 111,391 | ▼ 58% |
| Equity | € 1,401,028 | € 1,512,419 | ▲ 8% |
| Total debts | € 178,775 | € 131,457 | ▼ 26% |
| Cash | € 262,090 | € 199,565 | ▼ 24% |
| Retained profit | € 1,401,028 | € 1,512,419 | ▲ 8% |
| Balance sheet total | € 1,579,803 | € 1,643,876 | ▲ 4% |
Key figures of VACCINE MONITORING COLLABORATION FOR EUROPE, fiscal years 2023 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to VACCINE MONITORING COLLABORATION FOR EUROPE?
What happened at VACCINE MONITORING COLLABORATION FOR EUROPE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Eva MOLERO ROMEN stepped down as director. NBB
- Debabrata ROY stepped down as director. NBB
- Rosa GINI stepped down as director. NBB
- Giampiero MAZZAGLIA stepped down as director. NBB
- Naomi BOXALL stepped down as director. NBB
- Miriam STURKENBOOM stepped down as director. NBB
- Elisa BARBIERI stepped down as director. NBB
- Patrick MAHY stepped down as director. NBB
In short
From € 262,626 profit in 2023 to € 111,391 profit in 2024.
Best year ever: 2023, with € 262,626 profit.
A new publication or filing at VACCINE MONITORING COLLABORATION FOR EUROPE? We notify you, reason included.
Follow VACCINE MONITORING COLLABORATION FOR EUROPEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2024 annual accounts
Debabrata ROY
Director
since 2024 · until 2027
Rosa GINI
Director
since 2024 · until 2027
Giampiero MAZZAGLIA
Director
since 2024 · until 2027
Naomi BOXALL
Director
since 2024 · until 2027
Eva MOLERO ROMEN
Director
since 2024 · until 2027
Miriam STURKENBOOM
Director
since 2024 · until 2027
Elisa BARBIERI
Director
since 2024 · until 2027
Patrick MAHY
Director
since 2024 · until 2027
Establishments
Establishment units
Physical locations of this company
Washingtonstraat 40
1050 Elsene
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 75 companies are registered at this address.
All companies at this address →Association internationale pour les Mathématiques et les Calculateurs en Simulation - International Association for mathematics and Computers in Simulation
Comité Universitaire de Solidarit
Union des Associations internationales - UAI
€ 182,391 gross margin · 2025
INTERNATIONAL INSTITUTE OF SUGAR BEET RESEARCH
International Association for the Evaluation of Educational Achievement
+70 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0741.674.866
- VAT number
- BE 0741.674.866
- Registered office
- Washingtonstraat 40, 1050 Elsene
- Names & denominations
- VACCINE MONITORING COLLABORATION FOR EUROPE · VAC4EU
- Enterprise type
- Rechtspersoon
- Legal form
- International non-profit association
- Legal situation
- Normale toestand
- Start date
- 17 January 2020
- Peppol
- Active · Active since 22 Dec 2025
- Activities · NACE
Activiteiten op het gebied van voeding
Overige menselijke gezondheidszorg, n.e.g.